146 related articles for article (PubMed ID: 32871206)
1. Inhaled bosentan microparticles for the treatment of monocrotaline-induced pulmonary arterial hypertension in rats.
Lee HJ; Kwon YB; Kang JH; Oh DW; Park ES; Rhee YS; Kim JY; Shin DH; Kim DW; Park CW
J Control Release; 2021 Jan; 329():468-481. PubMed ID: 32871206
[TBL] [Abstract][Full Text] [Related]
2. Design and evaluation of novel inhalable sildenafil citrate spray-dried microparticles for pulmonary arterial hypertension.
Shahin HI; Vinjamuri BP; Mahmoud AA; Shamma RN; Mansour SM; Ammar HO; Ghorab MM; Chougule MB; Chablani L
J Control Release; 2019 May; 302():126-139. PubMed ID: 30940497
[TBL] [Abstract][Full Text] [Related]
3. Preparation and physicochemical characterization of spray-dried and jet-milled microparticles containing bosentan hydrate for dry powder inhalation aerosols.
Lee HJ; Kang JH; Lee HG; Kim DW; Rhee YS; Kim JY; Park ES; Park CW
Drug Des Devel Ther; 2016; 10():4017-4030. PubMed ID: 28008226
[TBL] [Abstract][Full Text] [Related]
4. Comparison of l-Carnitine and l-Carnitine HCL salt for targeted lung treatment of pulmonary hypertension (PH) as inhalation aerosols: Design, comprehensive characterization, in vitro 2D/3D cell cultures, and in vivo MCT-Rat model of PH.
Acosta MF; Muralidhran P; Abrahamson MD; Grijalva CL; Carver M; Tang H; Klinger C; Fineman JR; Black SM; Mansour HM
Pulm Pharmacol Ther; 2020 Dec; 65():101998. PubMed ID: 33556627
[TBL] [Abstract][Full Text] [Related]
5. In Vitro and In Vivo Performance of Novel Spray Dried Andrographolide Loaded Scleroglucan Based Formulation for Dry Powder Inhaler.
Mali AJ; Bothiraja C; Purohit RN; Pawar AP
Curr Drug Deliv; 2017; 14(7):968-980. PubMed ID: 27834151
[TBL] [Abstract][Full Text] [Related]
6. The Effect of Particle Size and Surface Roughness of Spray-Dried Bosentan Microparticles on Aerodynamic Performance for Dry Powder Inhalation.
Kwon YB; Kang JH; Han CS; Kim DW; Park CW
Pharmaceutics; 2020 Aug; 12(8):. PubMed ID: 32823545
[TBL] [Abstract][Full Text] [Related]
7. Formulation and evaluation of inhaled Sildenafil-loaded PLGA microparticles for treatment of pulmonary arterial hypertension (PAH): A novel high drug loaded formulation and scalable process via hot melt extrusion technology (Part Ⅰ).
Almutairi M; Hefnawy A; Almotairy A; Alobaida A; Alyahya M; Althobaiti A; Adel Ali Youssef A; Elkanayati RM; Ashour EA; Smyth HDC; Repka MA
Int J Pharm; 2024 Apr; 655():124044. PubMed ID: 38527563
[TBL] [Abstract][Full Text] [Related]
8. Development of Aerosol Phospholipid Microparticles for the Treatment of Pulmonary Hypertension.
Brousseau S; Wang Z; Gupta SK; Meenach SA
AAPS PharmSciTech; 2017 Nov; 18(8):3247-3257. PubMed ID: 28584899
[TBL] [Abstract][Full Text] [Related]
9. The role of lactose carrier on the powder behavior and aerodynamic performance of bosentan microparticles for dry powder inhalation.
Lee HJ; Lee HG; Kwon YB; Kim JY; Rhee YS; Chon J; Park ES; Kim DW; Park CW
Eur J Pharm Sci; 2018 May; 117():279-289. PubMed ID: 29510172
[TBL] [Abstract][Full Text] [Related]
10. Fasudil reduces monocrotaline-induced pulmonary arterial hypertension: comparison with bosentan and sildenafil.
Mouchaers KT; Schalij I; de Boer MA; Postmus PE; van Hinsbergh VW; van Nieuw Amerongen GP; Vonk Noordegraaf A; van der Laarse WJ
Eur Respir J; 2010 Oct; 36(4):800-7. PubMed ID: 20351034
[TBL] [Abstract][Full Text] [Related]
11. Tadalafil nanocomposites as a dry powder formulation for inhalation, a new strategy for pulmonary arterial hypertension treatment.
Teymouri Rad R; Dadashzadeh S; Vatanara A; Alavi S; Ghasemian E; Mortazavi SA
Eur J Pharm Sci; 2019 May; 133():275-286. PubMed ID: 30953751
[TBL] [Abstract][Full Text] [Related]
12. Development and Evaluation of Chitosan Microparticles Based Dry Powder Inhalation Formulations of Rifampicin and Rifabutin.
Pai RV; Jain RR; Bannalikar AS; Menon MD
J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):179-95. PubMed ID: 26406162
[TBL] [Abstract][Full Text] [Related]
13. Development of an inhaled controlled release voriconazole dry powder formulation for the treatment of respiratory fungal infection.
Arora S; Haghi M; Loo CY; Traini D; Young PM; Jain S
Mol Pharm; 2015 Jun; 12(6):2001-9. PubMed ID: 25923171
[TBL] [Abstract][Full Text] [Related]
14. Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers.
Li X; Vogt FG; Hayes D; Mansour HM
J Pharm Sci; 2014 Sep; 103(9):2937-2949. PubMed ID: 24740732
[TBL] [Abstract][Full Text] [Related]
15. Co-Spray Dried Mannitol/Poly(amidoamine)-Doxorubicin Dry-Powder Inhaler Formulations for Lung Adenocarcinoma: Morphology, In Vitro Evaluation, and Aerodynamic Performance.
Zhong Q
AAPS PharmSciTech; 2018 Feb; 19(2):531-540. PubMed ID: 28840529
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the effects of RP5063, a novel, multimodal, serotonin receptor modulator, as single-agent therapy and co-administrated with sildenafil, bosentan, and treprostinil in a monocrotaline-induced pulmonary arterial hypertension rat model.
Bhat L; Hawkinson J; Cantillon M; Reddy DG; Bhat SR; Laurent CE; Bouchard A; Biernat M; Salvail D
Eur J Pharmacol; 2018 May; 827():159-166. PubMed ID: 29453947
[TBL] [Abstract][Full Text] [Related]
17. Preparation and evaluation of poly(lactic-co-glycolic acid) microparticles as a carrier for pulmonary delivery of recombinant human interleukin-2: II. In vitro studies on aerodynamic properties of dry powder inhaler formulations.
Devrim B; Bozkır A; Canefe K
Drug Dev Ind Pharm; 2011 Nov; 37(11):1376-86. PubMed ID: 21548727
[TBL] [Abstract][Full Text] [Related]
18. Monocrotaline-Induced Pulmonary Arterial Hypertension and Bosentan Treatment in Rats: Focus on Plasma and Erythrocyte Parameters.
Jasenovec T; Radosinska D; Kollarova M; Vrbjar N; Balis P; Trubacova S; Paulis L; Tothova L; Shawkatova I; Radosinska J
Pharmaceuticals (Basel); 2022 Oct; 15(10):. PubMed ID: 36297339
[TBL] [Abstract][Full Text] [Related]
19. Inhaled sildenafil as an alternative to oral sildenafil in the treatment of pulmonary arterial hypertension (PAH).
Rashid J; Patel B; Nozik-Grayck E; McMurtry IF; Stenmark KR; Ahsan F
J Control Release; 2017 Mar; 250():96-106. PubMed ID: 28185800
[TBL] [Abstract][Full Text] [Related]
20. Microfluidic fabrication of inhalable large porous microspheres loaded with H
Zhang H; Hao LZ; Pan JA; Gao Q; Zhang JF; Kankala RK; Wang SB; Chen AZ; Zhang HL
J Control Release; 2021 Jan; 329():286-298. PubMed ID: 33279605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
